"At the Laurel Amtower Cancer Institute at Sharp Memorial, we battle cancer the best ways we know how — with cutting-edge treatments, advanced technologies, groundbreaking clinical research and complete dedication to your wellness and vitality. When it comes to cancer treatment at Sharp, we explore all possibilities. A leader in clinical oncology research, we offer clinical trials where new cancer treatments are discovered and put to use with positive outcomes. Our nationally accredited cancer services offer you the best of care every step of the way, from genetic counseling to diagnostic imaging to radiation therapy."

During the past decade, Sharp Memorial Hospital Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sharp Memorial Hospital Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Radiation Therapy Oncology Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sharp Memorial Hospital Cancer Center" are "Breast Cancer" (2 trials) and "Lymphoma" (2 trials). Many other conditions were trialed in "Sharp Memorial Hospital Cancer Center" in a lesser frequency.

Most popular intervention types in "Sharp Memorial Hospital Cancer Center" are "Biological" (2 trials), "Drug" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "autologous immunoglobulin idiotype-KLH conjugate vaccine" (2 trials), "sargramostim" (2 trials), "3-dimensional conformal accelerated partial breast irradiation" (1 trials), "MammoSite or other single-entry intracavitary device" (1 trials) and "axillary lymph node dissection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sharp Memorial Hospital Cancer Center" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Sharp Memorial Hospital Cancer Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sharp Memorial Hospital Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sharp Memorial Hospital Cancer Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".